The importance of prevention of calciphylaxis in patients who are at risk and the potential fallibility of calcimimetics in the treatment of calciphylaxis for patients with secondary hyperparathyroidism

NDT Plus

Volumn 3, Issue 1, 2010, Pages 68-70

  Khalpey, Zain ^a   Nehs, Matthew A ^a   Elbardissi, Andrew W ^a   Semel, Marcus ^a   Tullius, Stefan G ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

calciphylaxis; cinacalcet; hyperparathyroidism; sensipar

Indexed keywords

CALCIUM; CEFTAZIDIME; CINACALCET; CIPROFLOXACIN; METRONIDAZOLE; PARATHYROID HORMONE; PHOSPHORUS; THYMOCYTE ANTIBODY; VANCOMYCIN; WARFARIN;

ADULT; ARTICLE; BACTERIAL GROWTH; BIOPSY; CALCINOSIS; CALCIUM BLOOD LEVEL; CASE REPORT; CYTOKINE RELEASE SYNDROME; DRUG DOSE TITRATION; DRUG WITHDRAWAL; HEMODIALYSIS; HISTOPATHOLOGY; HUMAN; HYPOTENSION; KIDNEY FAILURE; KIDNEY TRANSPLANTATION; LUNG EMBOLISM; MALE; MEMBRANOUS GLOMERULONEPHRITIS; NECROSIS; PARATHYROID HORMONE BLOOD LEVEL; PARATHYROID HYPERPLASIA; PARATHYROIDECTOMY; PHOSPHATE BLOOD LEVEL; PRIORITY JOURNAL; RISK ASSESSMENT; SCLEROSIS; SECONDARY HYPERPARATHYROIDISM; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS INFECTION; THIGH; THROMBOSIS; TISSUE CULTURE; ULCER;

EID: 77955963571     PISSN: 17530784     EISSN: 17530792     Source Type: Journal    
DOI: 10.1093/ndtplus/sfp120     Document Type: Article

References (12)

1. Egbuna OI, Taylor JG, Bushinsky DA et al. Elevated calcium phosphate product after renal transplantation is a risk factor for graft failure. Clin Transplant 2007; 21: 558-566
2. Guldbakke K, Khachemoune A. Calciphylaxis. Int J Dermatol 2007; 46: 231-238
3. Nigwekar SU,Wolf M, SternsRHet al. Calciphylaxis from nonuremic causes: a systematic review. Clin J Am Soc Nephrol 2008; 3: 1139-1143
4. Bright T, JoukhadarR.Calciphylaxis in primary hyperparathyroidism: a case report and brief review. South Med J 2009; 102: 318-321
5. Don BR, Chin AI. Strategy for the treatment of calcific uremic arteriopathy (calciphylaxis) employing a combination of therapies. Clin Nephrol 2003; 59: 463-467
6. Araya CE, Fennell RS, Neiberger RE et al. Sodium thiosulfate treatment for calcific uremic arteriolopathy in children and young adults. Clin J Am Soc Nephrol 2006; 1: 1161-1166
7. BrucculeriM, Cheigh J, Bauer G et al. Long-termintravenous sodium thiosulfate in the treatment of a patient with calciphylaxis. Semin Dial 2005; 18: 431-434
8. Vassa N, Twardowski ZJ, Campbell J et al. hyperbaric oxygen therapy in calciphylaxis induced necrosis in peritoneal dialysis patients. Am. J Kidney Dis 1994; 23: 878-881
9. Basile C, Montanaro A, Masi M et al. Hyperbaric oxygen therapy for calcific uraemic arteiopathy: a case series. J Nephrol 2002; 15: 676-680
10. Barman Balfour JA, Scott LJ. Cinacalcet hydrochloride. Drugs 2005; 65: 271-281
11. Joy MS, Kshirsagar AV, Franceschini N. Calcimimetics and the treatment of primary and secondary hyperparathyroidism. Ann Pharmacother 2004; 38: 1871-1880
12. Velasco N, Mac Gregor MS, Innes A et al. Successful treatment of calciphylaxis with cinacalcet-an alternative to parathyroidectomy? Nephrol Dial Transplant 2006; 21: 1999-2004